Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$479,749
+$98,912 QoQ
Shares Held
1,889
+21.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#3,745
of 4,676 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AMERIFLEX GROUP, INC. holds $7,273,526 across 15 Drug Manufacturers - General names. JNJ ranks #6 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
7,386 | $2,674,618 | |
| 2 | ABBV |
AbbVie Inc.
|
3,842 | $966,800 | |
| 3 | LLY |
ELI LILLY & Co
|
759 | $910,367 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
11,913 | $686,427 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,176 | $536,616 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
1,889 | $479,749 | |
| 7 | AZN |
Astrazeneca PLC
|
1,973 | $374,120 | |
| 8 | PFE |
Pfizer Inc
|
12,810 | $308,464 |
All Filings in JNJ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $479,749 | 1,889 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $380,837 | 1,558 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $419,487 | 2,027 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $735,931 | 3,969 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $798,577 | 5,228 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $1,160,382 | 6,997 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $522,945 | 3,616 | Shares | Sole | 2025-02-24 | |
| No filing history on record for this holder in this stock. | ||||||